X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (146) 146
humans (140) 140
index medicus (124) 124
clinical neurology (112) 112
female (106) 106
male (104) 104
adult (103) 103
neurosciences (74) 74
middle aged (73) 73
magnetic resonance imaging (62) 62
neurology (58) 58
disability (53) 53
multiple sclerosis, relapsing-remitting - drug therapy (51) 51
disease progression (49) 49
treatment outcome (45) 45
interferon (41) 41
brain atrophy (37) 37
young adult (37) 37
natalizumab (34) 34
mri (33) 33
adolescent (32) 32
double-blind (31) 31
multiple sclerosis - drug therapy (31) 31
research (31) 31
interferon beta-1a (30) 30
care and treatment (28) 28
follow-up studies (28) 28
disability evaluation (27) 27
interferon-beta - therapeutic use (27) 27
progression (25) 25
placebo-controlled trial (24) 24
analysis (23) 23
abridged index medicus (22) 22
atrophy (22) 22
clinical trials (21) 21
double-blind method (21) 21
immunosuppressive agents - therapeutic use (21) 21
longitudinal studies (21) 21
multicenter (21) 21
brain - pathology (20) 20
drug therapy (20) 20
patients (20) 20
recurrence (20) 20
immunologic factors - therapeutic use (19) 19
multiple sclerosis - pathology (19) 19
multiple-sclerosis (19) 19
antibodies, monoclonal, humanized - therapeutic use (18) 18
cohort studies (18) 18
therapy (18) 18
nuclear magnetic resonance--nmr (17) 17
risk factors (17) 17
alemtuzumab (16) 16
multiple sclerosis, relapsing-remitting - pathology (16) 16
glatiramer acetate (15) 15
prospective studies (15) 15
time factors (15) 15
dimethyl fumarate (14) 14
disease (14) 14
interferon beta (14) 14
medicine & public health (14) 14
severity of illness index (14) 14
studies (14) 14
immunosuppressive agents - administration & dosage (13) 13
prognosis (13) 13
efficacy (12) 12
fingolimod (12) 12
health aspects (12) 12
lesions (12) 12
multiple sclerosis - diagnosis (12) 12
risk (12) 12
usage (12) 12
antibodies, monoclonal, humanized (11) 11
biological response modifiers (11) 11
brain - diagnostic imaging (11) 11
kaplan-meier estimate (11) 11
medicine, general & internal (11) 11
neuroimaging (11) 11
safety (11) 11
antibodies, monoclonal - therapeutic use (10) 10
brain (10) 10
clinically isolated syndrome (10) 10
clinically isolated syndromes (10) 10
diagnosis (10) 10
gadolinium (10) 10
immunosuppressive agents - adverse effects (10) 10
interferon-beta (10) 10
medical research (10) 10
neurology. diseases of the nervous system (10) 10
neuroradiology (10) 10
quality of life (10) 10
quality-of-life (10) 10
relapse (10) 10
relapsing-remitting multiple sclerosis (10) 10
cerebrospinal-fluid (9) 9
clinical medicine (9) 9
demyelinating diseases - drug therapy (9) 9
demyelination (9) 9
development and progression (9) 9
immunology (9) 9
impairment (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9648, pp. 1463 - 1472
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, p. e0169957
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2011, Volume 10, Issue 8, pp. 745 - 758
Journal Article
Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9856, pp. 1819 - 1828
Journal Article
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 6/2010, Volume 16, Issue 6, pp. 685 - 693
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2012, Volume 367, Issue 12, pp. 1087 - 1097
Journal Article